SLC5A2 and diabetes mellitus: According to the European Diabetes Research Association and the American Diabetes Association, GLP-1RAs, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, sodium-glucose cotransporter 2 inhibitors, and insulin are recommended as complementary drugs for patients whose blood sugar is not sufficiently controlled by metformin alone297.